224 related articles for article (PubMed ID: 12894520)
1. Sodium iodide symporter/radioactive iodine system has more efficient antitumor effect in three-dimensional spheroids.
Mitrofanova E; Hagan C; Qi J; Seregina T; Link C
Anticancer Res; 2003; 23(3B):2397-404. PubMed ID: 12894520
[TBL] [Abstract][Full Text] [Related]
2. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
Mitrofanova E; Unfer R; Vahanian N; Link C
Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
[TBL] [Abstract][Full Text] [Related]
3. Rat sodium iodide symporter for radioiodide therapy of cancer.
Mitrofanova E; Unfer R; Vahanian N; Daniels W; Roberson E; Seregina T; Seth P; Link C
Clin Cancer Res; 2004 Oct; 10(20):6969-76. PubMed ID: 15501976
[TBL] [Abstract][Full Text] [Related]
4. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
Spitzweg C; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
Cancer Res; 2000 Nov; 60(22):6526-30. PubMed ID: 11103823
[TBL] [Abstract][Full Text] [Related]
5. The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells.
Heltemes LM; Hagan CR; Mitrofanova EE; Panchal RG; Guo J; Link CJ
Cancer Gene Ther; 2003 Jan; 10(1):14-22. PubMed ID: 12489024
[TBL] [Abstract][Full Text] [Related]
6. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC
Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711
[TBL] [Abstract][Full Text] [Related]
7. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas.
Cho JY; Shen DH; Yang W; Williams B; Buckwalter TL; La Perle KM; Hinkle G; Pozderac R; Kloos R; Nagaraja HN; Barth RF; Jhiang SM
Gene Ther; 2002 Sep; 9(17):1139-45. PubMed ID: 12170377
[TBL] [Abstract][Full Text] [Related]
8. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
Dwyer RM; Bergert ER; O'connor MK; Gendler SJ; Morris JC
Clin Cancer Res; 2005 Feb; 11(4):1483-9. PubMed ID: 15746050
[TBL] [Abstract][Full Text] [Related]
9. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
10. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene.
Mandell RB; Mandell LZ; Link CJ
Cancer Res; 1999 Feb; 59(3):661-8. PubMed ID: 9973215
[TBL] [Abstract][Full Text] [Related]
11. Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models.
Carlin S; Cunningham SH; Boyd M; McCluskey AG; Mairs RJ
Cancer Gene Ther; 2000 Dec; 7(12):1529-36. PubMed ID: 11228531
[TBL] [Abstract][Full Text] [Related]
12. Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells.
Schipper ML; Weber A; Béhé M; Göke R; Joba W; Schmidt H; Bert T; Simon B; Arnold R; Heufelder AE; Behr TM
Cancer Res; 2003 Mar; 63(6):1333-8. PubMed ID: 12649195
[TBL] [Abstract][Full Text] [Related]
13. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.
Klutz K; Russ V; Willhauck MJ; Wunderlich N; Zach C; Gildehaus FJ; Göke B; Wagner E; Ogris M; Spitzweg C
Clin Cancer Res; 2009 Oct; 15(19):6079-86. PubMed ID: 19789324
[TBL] [Abstract][Full Text] [Related]
14. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
Scholz IV; Cengic N; Baker CH; Harrington KJ; Maletz K; Bergert ER; Vile R; Göke B; Morris JC; Spitzweg C
Gene Ther; 2005 Feb; 12(3):272-80. PubMed ID: 15510175
[TBL] [Abstract][Full Text] [Related]
15. Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose.
Haberkorn U; Kinscherf R; Kissel M; Kübler W; Mahmut M; Sieger S; Eisenhut M; Peschke P; Altmann A
Gene Ther; 2003 May; 10(9):774-80. PubMed ID: 12704416
[TBL] [Abstract][Full Text] [Related]
16. Approaches to gene therapy with sodium/iodide symporter.
Spitzweg C; Morris JC
Exp Clin Endocrinol Diabetes; 2001; 109(1):56-9. PubMed ID: 11573142
[TBL] [Abstract][Full Text] [Related]
17. In vivo sodium iodide symporter gene therapy of prostate cancer.
Spitzweg C; Dietz AB; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
Gene Ther; 2001 Oct; 8(20):1524-31. PubMed ID: 11704812
[TBL] [Abstract][Full Text] [Related]
18. Mitogen-activated protein kinase signaling enhances sodium iodide symporter function and efficacy of radioiodide therapy in nonthyroidal cancer cells.
Jung KH; Paik JY; Ko BH; Lee KH
J Nucl Med; 2008 Dec; 49(12):1966-72. PubMed ID: 18997042
[TBL] [Abstract][Full Text] [Related]
19. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
Willhauck MJ; Sharif Samani BR; Klutz K; Cengic N; Wolf I; Mohr L; Geissler M; Senekowitsch-Schmidtke R; Göke B; Morris JC; Spitzweg C
Gene Ther; 2008 Feb; 15(3):214-23. PubMed ID: 17989705
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroids.
Finocchiaro LM; Bumaschny VF; Karara AL; Fiszman GL; Casais CC; Glikin GC
Cancer Gene Ther; 2004 May; 11(5):333-45. PubMed ID: 15107812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
